The U.S. Supreme Court sided with Bayer's Monsanto, blocking thousands of cancer lawsuits over Roundup weedkiller. Shares jumped 17%.
Image source: MarketWatch
Bayer, the giant German company behind the popular weedkiller Roundup, just got a huge legal victory — and its stock price shot up because of it.
On Thursday, the U.S. Supreme Court (the highest court in America) ruled in favor of Bayer's subsidiary, Monsanto. The decision likely protects the company from tens of thousands of lawsuits claiming that Roundup caused cancer and that customers should have been warned.
Here are the key numbers:
The court's reasoning was about labels. The U.S. Environmental Protection Agency (EPA — the government body that regulates products affecting health and the environment) decided Roundup is unlikely to cause cancer. Because of this, the company is legally required to use a label *without* a cancer warning. Under federal law, individual states can't force their own different warning labels onto the product.
What this means: The ruling is expected to block current and future lawsuits claiming Roundup causes cancer. This removes a massive financial threat that had been hanging over Bayer for years — which is exactly why investors rushed to buy the stock, pushing the price up sharply.
In short, a big legal win lifted a major cloud of uncertainty, and Bayer's shareholders celebrated.
This is an AI-generated summary. Read the original article at: https://www.marketwatch.com/story/bayers-stock-jumps-after-supreme-court-sides-with-roundup-weedkiller-manufacturer-a747f253?mod=mw_rss_topstories